These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 9746444

  • 1. Antidepressant effect of transdermal nicotine patches in nonsmoking patients with major depression.
    Salín-Pascual RJ, Rosas M, Jimenez-Genchi A, Rivera-Meza BL, Delgado-Parra V.
    J Clin Psychiatry; 1996 Sep; 57(9):387-9. PubMed ID: 9746444
    [Abstract] [Full Text] [Related]

  • 2. Relationship between mood improvement and sleep changes with acute nicotine administration in non-smoking major depressed patients.
    Salin-Pascual RJ.
    Rev Invest Clin; 2002 Sep; 54(1):36-40. PubMed ID: 11995405
    [Abstract] [Full Text] [Related]

  • 3. Gepirone extended-release: new evidence for efficacy in the treatment of major depressive disorder.
    Feiger AD, Heiser JF, Shrivastava RK, Weiss KJ, Smith WT, Sitsen JM, Gibertini M.
    J Clin Psychiatry; 2003 Mar; 64(3):243-9. PubMed ID: 12716264
    [Abstract] [Full Text] [Related]

  • 4. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
    Alpert JE, Franznick DA, Hollander SB, Fava M.
    J Clin Psychiatry; 2004 Aug; 65(8):1069-75. PubMed ID: 15323591
    [Abstract] [Full Text] [Related]

  • 5. Using antipsychotic agents in older patients.
    Alexopoulos GS, Streim J, Carpenter D, Docherty JP, Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients.
    J Clin Psychiatry; 2004 Aug; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [Abstract] [Full Text] [Related]

  • 6. [Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city].
    Mouchabac S, Ferreri M, Cabanac F, Bitton M.
    Encephale; 2003 Aug; 29(5):438-44. PubMed ID: 14615693
    [Abstract] [Full Text] [Related]

  • 7. Depression, health-related quality of life, and medical cost outcomes of receiving recommended levels of antidepressant treatment.
    Revicki DA, Simon GE, Chan K, Katon W, Heiligenstein J.
    J Fam Pract; 1998 Dec; 47(6):446-52. PubMed ID: 9866670
    [Abstract] [Full Text] [Related]

  • 8. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder.
    Fava M, McCall WV, Krystal A, Wessel T, Rubens R, Caron J, Amato D, Roth T.
    Biol Psychiatry; 2006 Jun 01; 59(11):1052-60. PubMed ID: 16581036
    [Abstract] [Full Text] [Related]

  • 9. Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression.
    Schmidt PJ, Daly RC, Bloch M, Smith MJ, Danaceau MA, St Clair LS, Murphy JH, Haq N, Rubinow DR.
    Arch Gen Psychiatry; 2005 Feb 01; 62(2):154-62. PubMed ID: 15699292
    [Abstract] [Full Text] [Related]

  • 10. Tranylcypromine: patterns and predictors of response.
    White K, White J.
    J Clin Psychiatry; 1986 Jul 01; 47(7):380-2. PubMed ID: 3522559
    [Abstract] [Full Text] [Related]

  • 11. Nicotine patches and the subjective effects of cigarette smoking: a pilot study.
    Cárdenas L, Busto UE, MacDonald A, Corrigall WA.
    Can J Clin Pharmacol; 2002 Jul 01; 9(4):175-82. PubMed ID: 12584575
    [Abstract] [Full Text] [Related]

  • 12. Effectiveness of mirtazapine for nausea and insomnia in cancer patients with depression.
    Kim SW, Shin IS, Kim JM, Kim YC, Kim KS, Kim KM, Yang SJ, Yoon JS.
    Psychiatry Clin Neurosci; 2008 Feb 01; 62(1):75-83. PubMed ID: 18289144
    [Abstract] [Full Text] [Related]

  • 13. Dexamethasone for the treatment of depression: a preliminary report.
    Arana GW, Forbes RA.
    J Clin Psychiatry; 1991 Jul 01; 52(7):304-6. PubMed ID: 2071561
    [Abstract] [Full Text] [Related]

  • 14. Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode: a randomized open-label study.
    Amsterdam JD, Shults J.
    J Clin Psychopharmacol; 2008 Apr 01; 28(2):171-81. PubMed ID: 18344727
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Changes in compulsion and anxiety symptoms with nicotine transdermal patches in non-smoking obsessive-compulsive disorder patients.
    Salín-Pascual RJ, Basañez-Villa E.
    Rev Invest Clin; 2003 Apr 01; 55(6):650-4. PubMed ID: 15011734
    [Abstract] [Full Text] [Related]

  • 18. Double-blind comparison of citalopram and placebo in depressed outpatients with melancholia.
    Mendels J, Kiev A, Fabre LF.
    Depress Anxiety; 1999 Apr 01; 9(2):54-60. PubMed ID: 10207659
    [Abstract] [Full Text] [Related]

  • 19. Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation.
    Wohlreich MM, Mallinckrodt CH, Prakash A, Watkin JG, Carter WP.
    Depress Anxiety; 2007 Apr 01; 24(1):41-52. PubMed ID: 16845641
    [Abstract] [Full Text] [Related]

  • 20. Emotional withdrawal, CT abnormalities and drug response in late life depression.
    Altamura AC, Bassetti R, Santini A, Frisoni GB, Mundo E.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar 01; 28(2):349-54. PubMed ID: 14751432
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.